News – Page 105 – Endpoints News

Denali details accelerated approval plans; Jazz's $850M private offering

8 months ago

ProKidney axes one Phase 3 study, aims for 'expedited approval pathway' using another

8 months ago

With few specifics, Recursion underwhelms with first Phase 2 readout, but ‘plans to advance’ drug

8 months ago

Exclusive: PatientPartner raises $7M to help pharma companies match patients with mentors

8 months ago

Updated: Vaxcyte surges on Phase 1/2 data for 31-valent pneumococcal vaccine

8 months ago

Exclusive: Duke spinout launches in hopes of prevailing with brain cancer bispecific where Amgen, Roche did not

8 months ago

Arrowhead spotlights key pancreatitis figures from Phase 3 lipid disease study to differentiate itself from Ionis

8 months ago

Sanofi’s BTK inhibitor goes 1-for-3 in key MS trials, slows disability progression

8 months ago

Bayer’s Kerendia cuts heart death, failure and hospitalization by 16% in Phase 3 trial

8 months ago

FDA authorizes Novavax Covid booster; Recursion nears key data readouts; What’s next for CD47?; and more

8 months ago

FDA authorizes Novavax's updated Covid booster

8 months ago

Novo Nordisk reveals post-hoc cardiovascular data for semaglutide

8 months ago

Biosecure vote slated for September

8 months ago

Ipsen sells priority review voucher for highest price since 2016

8 months ago

FDA approves Emergent vaccine for mpox as company plans to donate 50,000 doses

8 months ago

Merck opens London lab as it makes push into immunology and the UK

8 months ago

Jacobio's China rights deal; Reneuron off the London exchange

8 months ago

Novo offers detailed look at semaglutide’s cardiac outcomes in Phase 3 trial as it tees up resubmission

8 months ago

NuCana stops Phase 2 as chemotherapy derivative 'unlikely' to meet primary endpoint

8 months ago

J&J's human resources leader to retire; Amgen becomes the newest pharma with a top AI exec

8 months ago

Updated: Alnylam’s new Phase 3 ATTR data bring uncertainty to standard of care ambitions

8 months ago

FDA’s drug evaluation wing launches new AI oversight panel

8 months ago

Pennsylvania judge sides with drugmakers on first steps for growing GLP-1 lawsuits

8 months ago

FDA hints at what Chevron's elimination means in new SCOTUS filing

8 months ago

First page Previous page 102 103 104105106 107 108 Next page Last page